ABBVIE INC. vs. Fortress Biotech, Inc.
ABBVIE INC. (ABBV) comes out ahead, leading on 5 of 9 compared factors.
Size & Scale
| ABBV | FBIO | |
|---|---|---|
| Market Cap | $435.06 billion | $92.68 million |
| Revenue (TTM) | $64.39 billion | $66.16 million |
| Net Income (TTM) | $6.32 billion | $128.94 million |
ABBV leads on 3 of 3 size & scale factors.
Valuation
| ABBV | FBIO | |
|---|---|---|
| P/E Ratio | 69.55 | 0.88 |
| Price / Book | -73.89 | 0.46 |
| Price / Sales | 6.76 | 1.40 |
FBIO leads on 2 of 3 valuation factors.
Profitability
| ABBV | FBIO | |
|---|---|---|
| Net Margin | 9.81% | 194.89% |
| Return on Equity | -107.29% | 63.71% |
FBIO leads on 2 of 2 profitability factors.
Dividend
| ABBV | FBIO | |
|---|---|---|
| Dividend Yield | 2.81% | — |
| Payout Ratio | 195.48 | — |
ABBV and FBIO split the dividend factors evenly.
Risk & Sentiment
| ABBV | FBIO | |
|---|---|---|
| Short Interest | 0.85% | 3.18% |
ABBV leads on 1 of 1 risk & sentiment factors.
Dig deeper: ABBV overview, ABBV financials, FBIO overview, FBIO financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.